Management of suboptimal response to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Re-induction therapy or direct to Radiotherapy?-Reference-Cited by-同舟云学术

Management of suboptimal response to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Re-induction therapy or direct to Radiotherapy?

Published:2021-10 Issue: Volume:163 Page:185-191
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Liu Ting,Liu Li-Ting,Lin Jie-Yi,Shen Bo-Wen,Guo Shan-Shan,Liu Sai-Lan,Sun Xue-Song,Liang Yu-Jing,Luo Mei-Juan,Li Xiao-Yun,Chen Qiu-Yan,Tang Lin-Quan,Mai Hai-Qiang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference35 articles.

1. Chen W, Zheng R, Baade PD et al. Cancer statistics in China, 2015. CA: A Cancer J Clin 2016;66(2):115–32. 10.3322/caac.21338.

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Tang L, Chen Y, Mao Y et al. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma from Endemic Areas in the Intensity-Modulated Radiotherapy Era. J Natl Compr Canc Ne 2017;15:913. 10.6004/jnccn.2017.0121.

4. Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline;Chen;J Clin Oncol.,2021

5. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions;Oral Oncology;2024-11

2. Incorporation of PD-1 blockade into induction chemotherapy improved tumor response in patients with locoregionally advanced nasopharyngeal carcinoma in a retrospective patient cohort;Oral Oncology;2024-07

3. Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma;Cell Reports Medicine;2024-06

4. Optimal cut‐off value for identifying objective response in patients with nasopharyngeal carcinoma after induction chemotherapy;Head & Neck;2024-03-28

5. Effect of waiting time for radiotherapy after last induction chemotherapy on prognosis of locally advanced nasopharyngeal carcinoma;Head & Neck;2024-02-17